A50.06 Early cutaneous congenital syphilis

Name of the Condition

• Early Cutaneous Congenital Syphilis

Summary

Early cutaneous congenital syphilis is a condition affecting infants under 2 years of age who acquired syphilis from their mother during pregnancy or delivery. It is characterized by skin manifestations resulting from the transplacental transmission of the Treponema pallidum bacterium. The condition may involve various skin lesions and can progress if untreated, potentially leading to systemic involvement.

Causes

Early cutaneous congenital syphilis is caused by the transplacental transmission of the Treponema pallidum bacterium from an infected mother to her child during pregnancy. The infection may also occur during delivery if the infant comes into contact with maternal genital lesions. Maternal syphilis infection during pregnancy, particularly if untreated or inadequately treated, is the primary cause.

Risk Factors

• Maternal syphilis infection during pregnancy, especially if untreated or inadequately treated.
• Lack of prenatal care or syphilis screening.
• High-risk behaviors in the mother, such as unprotected sex or substance use.

Symptoms

• Skin rashes, often on the palms, soles, or trunk.
• Papular, pustular, or bullous lesions.
• Scaling or desquamation of the skin.
• Possible mucous membrane involvement (e.g., mouth or genitalia).
• May present with other early congenital syphilis signs.

Diagnosis

Diagnosis involves a combination of clinical evaluation, maternal and infant serologic testing (e.g., nontreponemal and treponemal tests), and direct detection methods (e.g., dark-field microscopy or PCR) when available. Skin lesion biopsy may be considered for confirmation in ambiguous cases.

Treatment Options

Treatment typically involves parenteral penicillin G, the preferred agent for all stages of syphilis. Dosage and duration depend on the infant’s age, clinical presentation, and maternal treatment history. Follow-up serologic testing is recommended to monitor response.

Prognosis and Follow-Up

With prompt and appropriate treatment, the prognosis is generally good, though skin lesions may take time to resolve. Long-term follow-up is essential to monitor for late complications and ensure serologic normalization. Infants should be retested at 3, 6, and 12 months.

Complications

• Progression to late congenital syphilis if untreated.
• Potential for systemic involvement (e.g., bones, liver, or nervous system).
• Skin scarring or pigmentary changes from lesions.

Lifestyle & Prevention

• Prenatal screening and treatment of maternal syphilis are critical to prevent transmission.
• Safe sexual practices and regular testing for at-risk individuals.
• Avoidance of substance use during pregnancy to reduce risk factors.

When to Seek Professional Help

Seek immediate medical attention if an infant shows signs of skin lesions, fever, poor feeding, or other systemic symptoms, especially if maternal syphilis history is known or suspected.

Tips for Medical Coders

Document the presence of cutaneous manifestations and confirm the diagnosis with clinical or laboratory findings. Ensure the code A50.06 is used only for early cutaneous congenital syphilis, distinct from other early congenital syphilis presentations. Include details on maternal infection status and treatment history when available.